secwatch / observer
8-K filed December 4, 2024, 6:59 PM ET CIK 0001848437
regulatory confidence high sentiment negative materiality 0.35

Cartica Acquisition Corp: Nasdaq/NYSE listing notice — Cartica Acquisition Corp receives Nasdaq delisting notice for audit committee rule; cure period until 2025

Cartica Acquisition Corp

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.97

Cartica Acquisition Corp received a nasdaq deficiency notice notice regarding audit committee (rules 5605).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
audit committee
Rules
5605
Exact text from the filing
November 27, 2024, Cartica Acquisition Corp (the “Company”) received a written notice (the “Notice”) from The Nasdaq Stock Market (“Nasdaq”) indicating that the Company no longer complies with Nasdaq Listing Rule 5605 (the “Audit Committee Listing Rule”), which requires, among other things, companies with securities listed on Nasdaq to have an audit committee consisting of at least three members who are independent directors. The Company fell out of compliance with the Audit Committee Listing Rule as a result of the vacancy caused by the resignation of Kyle Ingvald Parent from the board of dir
View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR
accession 0001104659-24-125571
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.